title: Optimum management of Citrobacter koseri infection.
abstract: Low virulent Citrobacter koseri can cause life threatening infections. Neonates and other immunocompromised patients are particularly susceptible to infection from C. koseri. Any infection due to C. koseri mandates antimicrobial therapy based on the sensitivity of the pathogen microorganism. Various types of antibiotics, including aminoglycosides carbapenems, cephalosporins, chloramphenicol and quinolones, are used for the treatment of C. koseri infections. The rational choice of antimicrobial therapy for Citrobacter infections is a challenge for clinicians because there is a sustained increase in antibacterial resistance. We reviewed antimicrobial agents used for C. koseri infections in this review.
authors.affiliation: Department of Infectious Disease and Clinical Microbiology, Medical School, Ondokuz Mayis University, 55139, Samsun, Turkey.
authors.forename: Aydin
authors.initials: A
authors.lastname: Deveci
authors.forename: Ahmet Yilmaz
authors.initials: AY
authors.lastname: Coban
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D041041:Citrobacter koseri / Q000187:drug effects* / Q000235:genetics; D024881:Drug Resistance, Bacterial; D004756:Enterobacteriaceae Infections / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans
chemical_list: D000900:Anti-Bacterial Agents
keywords: Citrobacter koseri; infection; management; treatment